대한치매학회지 (Dementia and Neurocognitive Disorders)

대한치매학회 (Korean Dementia Association)
권호 표지

알츠하이머병 및 혈관성치매 환자에서 렘난트양지질단백콜레스테롤의 증가: 예비 연구

Elevated Remnant Lipoprotein Cholesterol in Patients with Alzheimer' Disease and Vascular Dementia: A Pilot Study

  • 심용수 (가톨릭대학교 의과대학 신경과학교실) ;
  • 심동석 (가톨릭대학교 의과대학 신경과학교실) ;
  • 윤보라 (건양대학교 의과대학 신경과학교실) ;
  • 신혜은 (가톨릭대학교 의과대학 신경과학교실) ;
  • 박상희 (가톨릭대학교 부천성모병원 임상의학연구소) ;
  • 강지민 (가톨릭대학교 의과대학 진단검사의학교실) ;
  • 양동원 (가톨릭대학교 의과대학 신경과학교실)
  • Shim, Yong-S. (Department of Neurology, The Catholic University of Korea School of Medicine) ;
  • Shim, Dong-Suk (Department of Neurology, The Catholic University of Korea School of Medicine) ;
  • Yoon, Bo-Ra (Department of Neurology, Konyang University School of Medicine) ;
  • Shin, Hye-Eun (Department of Neurology, The Catholic University of Korea School of Medicine) ;
  • Park, Sang-Hi (The institute of Clinical Medical Research of Bucheon St. Mary’ Hospital, The Catholic University of Korea School of Medicine) ;
  • Kang, Ji-Min (Department of Laboratory Medicine, The Catholic University of Korea School of Medicine) ;
  • Yang, Dong-Won (Department of Neurology, The Catholic University of Korea School of Medicine)
  • 발행 : 2010.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Cerebrovascular disease has been suggested as one of the mechanisms to explain the pathogenesis of Alzheimer' disease (AD) as well as vascular dementia (VaD). Although remnant lipoprotein (RLP) is strongly atherogenic and known as an independent risk factor of cardiovascular disease, there are few studies on the role in cerebrovascular disease. We conducted this study to evaluate the association between RLP and dementia, in terms of vascular etiology. Methods: Subjects were classified into 3 groups of control, AD and VaD. Plasma RLP cholesterol (RLP-C) concentrations were measured by the immunoseparation method. A total of 173 participants, who were 87 ADs, 28 VaDs, and 58 controls, were analyzed and age-matched. Results: RLP-C level was elevated in VaD (11.95${\pm}$6.67 mg/dL) and AD (10.04${\pm}$5.90 mg/dL) groups more than in control (6.31${\pm}$5.18 mg/dL) (p<0.001, ANCOVA). In addition to the control for age, the findings were also independent of the levels of triglyceride (TG), total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. The elevation of RLP-C level in AD and VaD was further distinct in subjects with normotriglyceridemia (p=0.001, ANCOVA). Conclusions: Our results demonstrated that RLP-C is elevated in VaD and AD, and can overcome the limitation of TG with heterogenous atherogenic particles. RLP-C might be a useful marker to indicate the cerebrovascular disease with large vessel problem.

키워드

참고문헌

  1. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosug Psychiatry 1999; 66: 137-47 https://doi.org/10.1136/jnnp.66.2.137
  2. Decarli C. Vascular factors in dementia: an overview. J Neurol Sci 2004; 226: 19-23 https://doi.org/10.1016/j.jns.2004.09.005
  3. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of alzheimer disease. the nun study. JAMA 1997; 277: 813-7 https://doi.org/10.1001/jama.277.10.813
  4. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003; 6: 345-51 https://doi.org/10.1038/nn0403-345
  5. Seman LJ, McNamara JR, Schaefer EJ. Lipoprotein(a), homocysteine, and remnant-like particles: emerging risk factors. Curr Opin Cardiol 1999; 14: 186-91 https://doi.org/10.1097/00001573-199903000-00017
  6. Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 2009; 16: 145-54 https://doi.org/10.5551/jat.E598
  7. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000; 86: 943-9 https://doi.org/10.1016/S0002-9149(00)01127-9
  8. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study. Circulation 1998; 97: 1029-36 https://doi.org/10.1161/01.CIR.97.11.1029
  9. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505-10 https://doi.org/10.1001/jama.269.4.505
  10. Lavie CJ, Milani RV. National cholesterol education program's recommendations and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs. Am J Cardiol 1991; 68: 1087-8 https://doi.org/10.1016/0002-9149(91)90500-K
  11. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-70 https://doi.org/10.1161/01.CIR.88.6.2762
  12. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middleaged men. Am J Cardiol 1996; 77: 1179-84 https://doi.org/10.1016/S0002-9149(96)00159-2
  13. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 223: 53-71 https://doi.org/10.1016/0009-8981(93)90062-9
  14. Cohn JS, Marcoux C, Davignon J. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol 1999; 19: 2474-86 https://doi.org/10.1161/01.ATV.19.10.2474
  15. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001; 154: 229-36 https://doi.org/10.1016/S0021-9150(00)00484-6
  16. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 1999; 99: 2858-60 https://doi.org/10.1161/01.CIR.99.22.2858
  17. Imke C, Rodriguez BL, Grove JS, McNamara JR, Waslien C, Katz AR, et al. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study. Arteriocler Thromb Vasc Biol 2005; 25: 1718-22 https://doi.org/10.1161/01.ATV.0000173310.85845.7b
  18. Masuoka H, Kamei S, Wagayama H, Ozaki M, Kawasaki A, Tanaka T, et al. Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels. Am Heart J 2000; 139: 305-10 https://doi.org/10.1016/S0002-8703(00)90240-0
  19. Uchiyama S, Yamazaki M, Iwata M. Remnant lipoprotein and lipoprotein (a) as risk factors for stroke and carotid disease. Int Congr Ser 2004; 1262: 478-81 https://doi.org/10.1016/j.ics.2003.12.042
  20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44 https://doi.org/10.1212/WNL.34.7.939
  21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60 https://doi.org/10.1212/WNL.43.2.250
  22. Kang YW, Na DL, Hahn SH. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997; 15: 300-8
  23. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-4
  24. Yoon B, Kim YD, Yang DW, Shim YS. Serum uric acid level according to the severity of white matter changes in Alzheimer's disease. Dementia and Neurocognitive Disorders 2009; 8: 135-9
  25. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1-4 https://doi.org/10.1161/01.CIR.95.1.1
  26. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 1986; 256: 2835-8 https://doi.org/10.1001/jama.256.20.2835
  27. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL. Myocardial infarction in familial forms of hypertriglyceridemia. Metabolism 1976; 25: 313-20 https://doi.org/10.1016/0026-0495(76)90089-5
  28. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized lowdensity lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 2004; 109: 1022-8 https://doi.org/10.1161/01.CIR.0000117403.64398.53
  29. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide SI, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000; 102: 670-6 https://doi.org/10.1161/01.CIR.102.6.670
  30. Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation 2003; 108: 2679-88 https://doi.org/10.1161/01.CIR.0000093278.75565.87
  31. Saniabadi AR, Umemura K, Shimoyama M, Adachi M, Nakano M, Nakashima M. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Haemost 1997; 77: 996-1001
  32. Snowdon DA. Aging and Alzheimer's disease: lessons from the nun study. Gerontologist 1997; 37: 150-6 https://doi.org/10.1093/geront/37.2.150
  33. Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 2004; 26: 525-39 https://doi.org/10.1179/016164104225017668
  34. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003; 23: 2055-62 https://doi.org/10.1161/01.ATV.0000095973.42032.44
  35. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623-7 https://doi.org/10.1161/01.STR.0000143317.70478.b3
  36. Roher AE, Kokjohn TA, Beach TG. An association with great implications: vascular pathology and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20: 73-5 https://doi.org/10.1097/01.wad.0000201855.39246.2d
  37. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997; 349: 151-4 https://doi.org/10.1016/S0140-6736(96)09328-2
  38. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 2003; 34: 335-7 https://doi.org/10.1161/01.STR.0000054050.51530.76
  39. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005; 57: 789-94 https://doi.org/10.1002/ana.20493
  40. Staekenborg SS, van Straaten ECW, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: risk factors and MRI finsdings. J Neurol 2008; 255: 1644-51 https://doi.org/10.1007/s00415-008-0944-1
  41. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23-30
  42. Nakamura T, Obata JE, Takano H, Kawabata K, Sano K, Kobayashi T, et al. High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis. Atherosclerosis 2009; 202: 234-40 https://doi.org/10.1016/j.atherosclerosis.2008.03.018